Upstream Metabolics, Inc. — SEC Form D Filing
Upstream Metabolics, Inc. filed an SEC Form D on September 29, 2026, reporting $50K raised in Other Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- September 29, 2026
- Amount reported
- $50K
- Round stage
- Pre-seed, as a fifty-thousand-dollar SAFE raise represents an initial friends-and-family or incubator round to secure early intellectual property.
- Industry
- Other Health Care
- Website
- https://upstreammetabolics.com
What the company does
Securities: Simple Agreement for Future Equity (SAFE). Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Biopharmaceutical researchers and clinicians lack precise tools to identify and target early-stage metabolic pathway dysfunctions before they manifest as chronic systemic diseases.
Solution
Upstream Metabolics develops advanced metabolic profiling assays and software to map early-stage cellular metabolic pathways for targeted therapeutic discovery.
Why now
Recent breakthroughs in high-throughput metabolomics and machine learning-driven pathway analysis have made it commercially viable to map complex cellular metabolic interactions at unprecedented resolution.
Source: SEC EDGAR Form D filing